Plerixafor in patients with lymphoma and multiple myeloma: Effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization

1. Sánchez-Ortega, I.
2. Querol, S.
3. Encuentra, M.
4. Ortega, S.
5. Serra, A.
6. Sanchez-Villegas, J.M.
7. Grifols, J.R.
8. Pujol-Balaguer, M.M.
9. Pujol-Bosch, M.
10. Martí, J.M.
11. Garcia-Cerecedo, T.
12. Barba, P.
13. Sancho, J.M.
14. Esquirol, A.
15. Sierra, J.
16. Duarte, R.F.